0001677995-26-000003.txt : 20260806 0001677995-26-000003.hdr.sgml : 20260806 20260806143355 ACCESSION NUMBER: 0001677995-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260806 DATE AS OF CHANGE: 20260806 EFFECTIVENESS DATE: 20260806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cerium Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001677995 ORGANIZATION NAME: EIN: 454872095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-593360 FILM NUMBER: 261248264 BUSINESS ADDRESS: STREET 1: 312 MAIN STREET STREET 2: SUITE 200 CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 3019632400 MAIL ADDRESS: STREET 1: 312 MAIN STREET STREET 2: SUITE 200 CITY: GAITHERSBURG STATE: MD ZIP: 20878 D 1 primary_doc.xml X0708 D LIVE 0001677995 Cerium Pharmaceuticals, Inc. 312 MAIN STREET SUITE 300 GAITHERSBURG MD MARYLAND 20878 703-229-2508 DELAWARE None None Corporation true Gregg A. Lapointe 312 Main St., Ste. 300 Gaithersburg MD MARYLAND 20878 Executive Officer Director Peter Collum 312 Main St., Ste. 300 Gaithersburg MD MARYLAND 20878 Director Steve Eskenazi 312 Main St., Ste. 300 Gaithersburg MD MARYLAND 20878 Director Robert Rubin 312 Main St., Ste. 300 Gaithersburg MD MARYLAND 20878 Director Tom DePasquale 312 Main St., Ste. 300 Gaithersburg MD MARYLAND 20878 Director James Gale 312 Main St., Ste. 300 Gaithersburg MD MARYLAND 20878 Director Pharmaceuticals Decline to Disclose 06b false 2026-05-22 false true false 0 2544000 750000 1794000 false 4 0 0 0 true Excludes standard compensation for officers and directors. false Cerium Pharmaceuticals, Inc. /s/ Gregg A. Lapointe Gregg A. Lapointe CEO 2026-08-06